Guidance for industry : S1C(R2) dose selection for carcinogenicity studies.
Other author/creator | Center for Drug Evaluation and Research (U.S.) |
Other author/creator | Center for Biologics Evaluation and Research (U.S.) |
Other author/creator | International Conference on Harmonisation. |
Format | Electronic and Book |
Publication Info | Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; [Rockville, MD] : Center for Biologics Evaluation and Research, [2008] |
Description | i, 10 p. : digital, PDF file |
Supplemental Content | https://purl.fdlp.gov/GPO/LPS111012 |
Subject(s) |
Click here for more information about this title
Portion of title | Dose selection for carcinogenicity studies |
General note | Title from PDF title page (viewed on Apr. 6, 2009). |
General note | "ICH." |
General note | "Revision 1." |
General note | "September 2008." |
General note | GPO Cataloging Record Distribution Program (CRDP). |
Technical details | Mode of access: Internet at the FDA CDER Web site. Address as of 4/06/09: http://www.fda.gov/cder/guidance/8349fnl.pdf ; current access is available via PURL. |
GPO item number | 0499-T-02 (online) |
Govt. docs number | HE 20.4802:C 17 |
Available Items
Library | Location | Call Number | Status | Item Actions | |
Joyner | Electronic Resources | Access Content Online | ✔ Available |